814 related articles for article (PubMed ID: 26658161)
21. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
Fearns C; Pan Q; Mathison JC; Chuang TH
J Biol Chem; 2006 Nov; 281(45):34592-600. PubMed ID: 16968706
[TBL] [Abstract][Full Text] [Related]
22. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
[TBL] [Abstract][Full Text] [Related]
23. The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death.
Yoo L; Chung KC
J Biol Chem; 2018 Jan; 293(4):1286-1297. PubMed ID: 29242192
[TBL] [Abstract][Full Text] [Related]
24. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
[TBL] [Abstract][Full Text] [Related]
25. The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.
Hanoun N; Fritsch S; Gayet O; Gigoux V; Cordelier P; Dusetti N; Torrisani J; Dufresne M
J Biol Chem; 2014 Dec; 289(51):35593-604. PubMed ID: 25355311
[TBL] [Abstract][Full Text] [Related]
26. USP19-Mediated Deubiquitination Facilitates the Stabilization of HRD1 Ubiquitin Ligase.
Harada K; Kato M; Nakamura N
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827840
[TBL] [Abstract][Full Text] [Related]
27. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
28. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
[TBL] [Abstract][Full Text] [Related]
29. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase.
Singh AK; Pati U
Aging Cell; 2015 Aug; 14(4):595-604. PubMed ID: 25773675
[TBL] [Abstract][Full Text] [Related]
30. K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains.
Ohtake F; Tsuchiya H; Saeki Y; Tanaka K
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1401-E1408. PubMed ID: 29378950
[TBL] [Abstract][Full Text] [Related]
31. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
Li P; Kurata Y; Maharani N; Mahati E; Higaki K; Hasegawa A; Shirayoshi Y; Yoshida A; Kondo T; Kurozawa Y; Yamamoto K; Ninomiya H; Hisatome I
J Mol Cell Cardiol; 2015 Sep; 86():138-46. PubMed ID: 26232501
[TBL] [Abstract][Full Text] [Related]
32. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
Marx C; Held JM; Gibson BW; Benz CC
Cancer Res; 2010 May; 70(9):3709-17. PubMed ID: 20406983
[TBL] [Abstract][Full Text] [Related]
33. CHIP and BAP1 Act in Concert to Regulate INO80 Ubiquitination and Stability for DNA Replication.
Seo HR; Jeong D; Lee S; Lee HS; Lee SA; Kang SW; Kwon J
Mol Cells; 2021 Feb; 44(2):101-115. PubMed ID: 33658435
[TBL] [Abstract][Full Text] [Related]
34. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.
Xie Y; Avello M; Schirle M; McWhinnie E; Feng Y; Bric-Furlong E; Wilson C; Nathans R; Zhang J; Kirschner MW; Huang SM; Cong F
J Biol Chem; 2013 Feb; 288(5):2976-85. PubMed ID: 23184937
[TBL] [Abstract][Full Text] [Related]
35. RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.
Yang L; Zhou B; Li X; Lu Z; Li W; Huo X; Miao Z
Cell Physiol Biochem; 2015; 35(1):237-45. PubMed ID: 25591766
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
37. Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
Xie J; Gu J
J Cell Mol Med; 2015 Aug; 19(8):1814-24. PubMed ID: 25818514
[TBL] [Abstract][Full Text] [Related]
38. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
[TBL] [Abstract][Full Text] [Related]
39. Post-translational modification of OCT4 in breast cancer tumorigenesis.
Cho Y; Kang HG; Kim SJ; Lee S; Jee S; Ahn SG; Kang MJ; Song JS; Chung JY; Yi EC; Chun KH
Cell Death Differ; 2018 Nov; 25(10):1781-1795. PubMed ID: 29511337
[TBL] [Abstract][Full Text] [Related]
40. Geranylgeranylacetone promotes human osteosarcoma cell apoptosis by inducing the degradation of PRMT1 through the E3 ubiquitin ligase CHIP.
Jiang L; Liao J; Liu J; Wei Q; Wang Y
J Cell Mol Med; 2021 Aug; 25(16):7961-7972. PubMed ID: 34155784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
